about
Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?Molecular Pathways Regulating Macrovascular Pathology and Vascular Smooth Muscle Cells Phenotype in Type 2 DiabetesNewly diagnosed diabetes mellitus as a risk factor for serious liver diseaseRefitting of the UKPDS 68 risk equations to contemporary routine clinical practice data in the UK.Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activatorsAnti-inflammatory properties of C-Peptide.Intracellular Ca2+ regulating proteins in vascular smooth muscle cells are altered with type 1 diabetes due to the direct effects of hyperglycemia.Effects of Hyperglycemia on Vascular Smooth Muscle Ca2+ SignalingNovel risk factors in long-term hypertension incidence in type 1 diabetes mellitusMetabolic memory: a vascular perspective.Early alterations in vascular contractility associated to changes in fatty acid composition and oxidative stress markers in perivascular adipose tissue.Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitusLin28a protects against hypoxia/reoxygenation induced cardiomyocytes apoptosis by alleviating mitochondrial dysfunction under high glucose/high fat conditions.N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes.Insulin resistance, diabetes mellitus, and brain structure in bipolar disordersDifferential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice.Renal protective effects of Porphyra dentate aqueous extract in diabetic miceOxidative stress and the etiology of insulin resistance and type 2 diabetes.Microangiopathy is common in submucosal vessels of the colon in patients with diabetes mellitus.High glucose-treated macrophages augment E-selectin expression in endothelial cells.Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathyIn women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the NationImprovement of pulmonary function with arm swing exercise in patients with type 2 diabetesAlteration of mevalonate pathway in proliferated vascular smooth muscle from diabetic mice: possible role in high-glucose-induced atherogenic process.Advanced glycation end-products induce apoptosis in pancreatic islet endothelial cells via NF-κB-activated cyclooxygenase-2/prostaglandin E2 up-regulation.Interactive effects of a common γ-glutamyltransferase 1 variant and low high-density lipoprotein-cholesterol on diabetic macro- and micro-angiopathySenescent Cells Impair Erectile Function through Induction of Endothelial Dysfunction and Nerve Injury in Mice.Hepatic arteriolosclerosis: a small-vessel complication of diabetes and hypertension.Effect of intensive multifactorial treatment on the intima-media thickness of large arteries in patients with new-onset type 2 diabetes mellitus.Diabetes-related alterations in the enteric nervous system and its microenvironment.Type 2 diabetes mellitus is associated with an imbalance in circulating endothelial and smooth muscle progenitor cell numbers.Combining laser-Doppler flowmetry measurements with spectral analysis to study different microcirculatory effects in human prediabetic and diabetic subjects.Subcellular proteomic approach for identifying the signaling effectors of protein kinase C-β₂ under high glucose conditions in human umbilical vein endothelial cellsType 1 diabetes: Developing the first risk-estimation model for predicting silent myocardial ischemia. The potential role of insulin resistance.Insulin treatment increases myocardial ceramide accumulation and disrupts cardiometabolic functionVasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies?Diabetes and Its Effect on Bone and Fracture Healing.Genetically Low Antioxidant Protection and Risk of Cardiovascular Disease and Heart Failure in Diabetic Subjects.Effect of Dipeptidyl Peptidase-4 Inhibitor on All-Cause Mortality and Coronary Revascularization in Diabetic Patients.High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications.
P2860
Q26745606-35195247-F6C6-4C3B-AA69-FC41CB771800Q26782445-1320E67F-7AB6-482F-A3AB-016CDE7680D3Q30495922-909C139C-5CA4-4260-9BE0-1316759DE6A4Q30863970-53506A92-54D1-47E0-B46F-B32EF31004C0Q33675244-12678E70-A50D-47A6-85B4-CEB45BEC54CEQ33682573-154AD12A-8FAD-4F11-8E3F-BB51CA076029Q33691901-CF09869A-6D2E-4A0A-8C36-620F57386D87Q33872775-D858A15D-0959-4775-9770-5461AADF0880Q33940455-5822B400-DFC7-49B2-8F41-19D3672537D4Q34158068-8E6F7FD1-7BAE-49A0-9372-0E024C5EE026Q34282630-946B039D-4159-46E2-99F5-18C544C0D8DBQ34332026-E6EB53FB-7C32-4F5A-8018-80BF74553004Q34338583-7AC9A3E9-2629-4264-9E7C-B127A097D8EBQ34351254-BD824687-DA45-4B79-964A-C32339DFA848Q34357070-50F992FC-C5A5-43DA-899B-DC1624B95C58Q34399952-9542671F-E1A5-4128-9894-0A90A69C74FFQ34691804-5823CDE6-6B69-44C0-88A9-055BAC7DE89FQ34768229-AE659645-04CD-4141-9339-E13A12A9871CQ35025217-D17FFD6F-57A6-4177-97A3-2A4901A5610DQ35111015-30C25044-2602-4C5A-AFEA-94BA4984BC57Q35317010-54092597-D67F-4290-B90D-D6ACBB612D9AQ35327367-C5561AA8-BCC7-46A7-8913-B2F595C18400Q35397900-5B5A10B8-6B5E-4C63-941C-EB306FC7AD74Q35415550-5F5CD089-2B47-4C7D-B628-3DD6E0822BADQ35512499-543E0FD7-0780-4E7C-9C24-A0D598BCCB9FQ35595619-2A67D81B-3D80-4345-B34F-6613DF3428BBQ35610039-A782872D-A446-44B6-929B-095E4C7C53A4Q35738426-CDB8EDA6-EA65-46AD-B5A5-7449884FBD35Q35946407-22B93A4E-F879-4C07-BE5D-D54608DCEC79Q35988135-763F9FAB-1C45-4FD6-A3DC-8DF78AF083E5Q36138219-9B0CEB12-7CDF-41A7-B0E9-CD1332DA983FQ36215579-2B1CD6B0-2443-4539-ADF7-82FCC5C0904DQ36224900-93E46E4C-B5BD-4C6A-9803-903AE032B48FQ36332106-4DCF68F5-6FE1-4332-96B9-335B0FFB2983Q36383552-4DB29728-539C-4EAA-9E98-D6E89E40A49EQ36384149-FD6E9B96-FD02-4BC5-BA4A-7DEE6D49C53AQ36407732-01BFA730-FDAD-4C42-8B81-C635BE2EAC13Q36437769-0CF3A692-9B18-495A-9330-28233DC62820Q36448319-6D1710A7-A44E-416F-AA8E-9D2E67CC4469Q36616550-60277C8C-6CD2-498D-B931-92C560A1DF44
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The pathologic continuum of diabetic vascular disease.
@en
The pathologic continuum of diabetic vascular disease.
@nl
type
label
The pathologic continuum of diabetic vascular disease.
@en
The pathologic continuum of diabetic vascular disease.
@nl
prefLabel
The pathologic continuum of diabetic vascular disease.
@en
The pathologic continuum of diabetic vascular disease.
@nl
P2860
P1476
The pathologic continuum of diabetic vascular disease.
@en
P2093
Gabriela Orasanu
Jorge Plutzky
P2860
P304
P356
10.1016/J.JACC.2008.09.055
P407
P433
P577
2009-02-01T00:00:00Z